Congress blocks federal research into transgender youth medical care
S. 5202 — Protecting Our Kids from Harmful Research Act · Filed by Mike Lee (R-UT) · 6 cosponsors · Introduced Jul 30, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill prohibits federal funding for research or publications about gender transition treatments (hormones or surgery) in minors under 18. It defines sex solely by reproductive biology and genetics at birth, and bars funding for studies that would affirm a minor's gender identity if it differs from sex assigned at birth.
Why we flagged it
The bill's operative mechanism is a categorical prohibition on federal research funding for a specific medical topic in a specific population. It does not regulate clinical practice directly, does not criminalize treatment, and does not restrict private funding — it narrows the scope of federally-supported research.
What the text implies
- Blocks not only clinical trials but also observational studies and epidemiological research, which may eliminate data on prevalence, outcomes, and harms/benefits — constraining evidence base for future policy and clinical decisions.
- Defines sex by 'reproductive biology and genetics at birth' — a statutory definition that may have downstream effects on other federal programs, regulations, or legal interpretations if cited as precedent.
The full analysis lists 4 implications of this text.
Who it affects
The bill restricts research funding, which may reduce evidence available to inform medical practice and policy — a potential cost to youth seeking care and clinicians making treatment decisions. However, the bill reflects a legitimate policy disagreement about whether federal funds should support research into pediatric gender transition, a contested medical and ethical question where reasonable people differ on appropriate federal role.